Latest Headlines

Latest Headlines

Ceva combats chlamydia in Australian koalas with new drug supply program

Ceva Santé Animale is taking an active role in helping wipe out chlamydia in Australian koalas, donating supplies to animal health centers and one of the continent's top zoos to cure animals of the sexually transmitted disease.

Researchers ready consumer STD-detecting, connected ring for Indiegogo in early 2016

An international entrepreneurial trio has developed a hand-worn ring that detects syphilis, gonorrhea, chlamydia and trichomoniasis--wirelessly transmitting the results to a smartphone or tablet in under one minute. Known as Hoope, the device has a retractable needle and an anesthetic system based on electrical pulses; it is slated to debut on crowdfunding site Indiegogo in January.

U.K.'s Prokarium scores $585,000 for oral chlamydia vaccine

Prokarium, which specializes in developing oral vaccines announced £377,000 ($585,000) in new funding from SynbiCITE, the U.K.'s Innovation and Knowledge Centre for Synthetic Biology. It will go toward the development of an oral chlamydia vaccine.

Oral vax rides on advanced microparticles

Researchers in the U.S. and China have worked together to develop microparticles that carry vaccine nanoparticles through the stomach and release them in the large intestine when the pH levels are on point.

Chlamydia vaccine protects in animal studies

The vaccine developer Genocea Biosciences has used its in-house proteomics screening technology, AnTigen Lead Acquisition System (ATLAS), to identify two potential candidates for C trachomatis vaccines.